Alpha 2.0
Login Register
» Authors » Lisette A van Berkel

Lisette A van Berkel

Explore the profile of Lisette A van Berkel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 340
Followers 0
Related Specialties
Allergy & Immunology
Science
Gastroenterology
Top 10 Co-Authors
Janneke N Samsom
Georg Kraal
Wendy W J Unger
Johanna C Escher
Reina E Mebius
Edward E S Nieuwenhuis
Wendy Jansen
Lissy de Ridder
Ytje Simons-Oosterhuis
Nicholas M Croft
Published In
J Immunol
Mucosal Immunol
Gastroenterology
Ann N Y Acad Sci
Sci Rep
Affiliations
Soon will be listed here.
Recent Articles
1.
Gut-homing and intestinal TIGITCD38 memory T cells acquire an IL-12-induced, ex-Th17 pathogenic phenotype in a subgroup of Crohn's disease patients with a severe disease course
Heredia M, Barendregt D, Tindemans I, Klomberg R, Aardoom M, Calado B, et al.
Mucosal Immunol . 2024 Nov; PMID: 39586377
CD4 memory T cell (T) reactivation drives chronicity in inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis. Defects driving loss of T regulation likely differ between patients...
2.
Combined plasma protein and memory T cell profiling discern IBD-patient-immunotypes related to intestinal disease and treatment outcomes
Heredia M, Charrout M, Klomberg R, Aardoom M, Jongsma M, Kemos P, et al.
Mucosal Immunol . 2024 Sep; 18(1):76-89. PMID: 39332767
Inflammatory bowel disease (IBD) chronicity results from memory T helper cell (Tmem) reactivation. Identifying patient-specific immunotypes is crucial for tailored treatment. We conducted a comprehensive study integrating circulating immune proteins...
3.
The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease
Bourgonje A, Hu S, Spekhorst L, Zhernakova D, Vich Vila A, Li Y, et al.
J Crohns Colitis . 2021 Sep; 16(3):414-429. PMID: 34491321
Background And Aims: Protein profiling in patients with inflammatory bowel diseases [IBD] for diagnostic and therapeutic purposes is underexplored. This study analysed the association between phenotype, genotype, and the plasma...
4.
Frequencies of circulating regulatory TIGITCD38 effector T cells correlate with the course of inflammatory bowel disease
Joosse M, Menckeberg C, de Ruiter L, Raatgeep H, van Berkel L, Simons-Oosterhuis Y, et al.
Mucosal Immunol . 2018 Aug; 12(1):154-163. PMID: 30127383
Disease heterogeneity hampers achieving long-term disease remission in inflammatory bowel disease (IBD). Monitoring ongoing tissue-localized regulatory and inflammatory T-cell responses in peripheral blood would empower disease classification. We determined whether...
5.
Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
Perdicchio M, Ilarregui J, Verstege M, Cornelissen L, Schetters S, Engels S, et al.
Proc Natl Acad Sci U S A . 2016 Mar; 113(12):3329-34. PMID: 26941238
Sialic acids are negatively charged nine-carbon carboxylated monosaccharides that often cap glycans on glycosylated proteins and lipids. Because of their strategic location at the cell surface, sialic acids contribute to...
6.
Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses
Rossi O, van Berkel L, Chain F, Tanweer Khan M, Taverne N, Sokol H, et al.
Sci Rep . 2016 Jan; 6:18507. PMID: 26725514
Faecalibacterium prausnitzii strain A2-165 was previously reported to have anti-inflammatory properties and prevent colitis in a TNBS model. We compared the immunomodulatory properties of strain A2-165 to four different F....
7.
Tolerance to ingested deamidated gliadin in mice is maintained by splenic, type 1 regulatory T cells
du Pre M, Kozijn A, van Berkel L, Ter Borg M, Lindenbergh-Kortleve D, Jensen L, et al.
Gastroenterology . 2011 Jun; 141(2):610-20, 620.e1-2. PMID: 21683079
Background & Aims: Patients with celiac disease have permanent intolerance to gluten. Because of the high frequency of this disorder (approximately 1 in 100 individuals), we investigated whether oral tolerance...
8.
CD62L(neg)CD38⁺ expression on circulating CD4⁺ T cells identifies mucosally differentiated cells in protein fed mice and in human celiac disease patients and controls
du Pre M, van Berkel L, Raki M, van Leeuwen M, de Ruiter L, Broere F, et al.
Am J Gastroenterol . 2011 Mar; 106(6):1147-59. PMID: 21386831
Objectives: The aim of this study was to identify new markers of mucosal T cells to monitor ongoing intestinal immune responses in peripheral blood. Methods: Expression of cell-surface markers was...
9.
Secretory leukoprotease inhibitor in mucosal lymph node dendritic cells regulates the threshold for mucosal tolerance
Samsom J, van der Marel A, van Berkel L, van Helvoort J, Simons-Oosterhuis Y, Jansen W, et al.
J Immunol . 2007 Nov; 179(10):6588-95. PMID: 17982048
The notion that the mucosal immune system maintains a tolerogenic response to harmless Ags while continually being challenged with microbial products seems an enigma. The aim of this study was...
10.
Blockade of IDO inhibits nasal tolerance induction
van der Marel A, Samsom J, Greuter M, van Berkel L, OToole T, Kraal G, et al.
J Immunol . 2007 Jul; 179(2):894-900. PMID: 17617580
The amino acid tryptophan is essential for the proliferation and survival of cells. Modulation of tryptophan metabolism has been described as an important regulatory mechanism for the control of immune...